72 related articles for article (PubMed ID: 10487799)
1. Increasing the impact of cardiological treatments. How best to reduce deaths.
Capewell S; Pell JP; Morrison C; McMurray J
Eur Heart J; 1999 Oct; 20(19):1386-92. PubMed ID: 10487799
[TBL] [Abstract][Full Text] [Related]
2. The population mortality benefits of maximizing the number of eligible patients receiving appropriate cardiology treatments in Ireland.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley J; Feely J; Capewell S
QJM; 2006 Aug; 99(8):523-30. PubMed ID: 16861717
[TBL] [Abstract][Full Text] [Related]
3. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994.
Capewell S; Morrison CE; McMurray JJ
Heart; 1999 Apr; 81(4):380-6. PubMed ID: 10092564
[TBL] [Abstract][Full Text] [Related]
4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
Critchley J; Liu J; Zhao D; Wei W; Capewell S
Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
[TBL] [Abstract][Full Text] [Related]
5. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
Fidan D; Unal B; Critchley J; Capewell S
QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875
[TBL] [Abstract][Full Text] [Related]
6. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000.
Kabir Z; Bennett K; Shelley E; Unal B; Critchley JA; Capewell S
BMC Public Health; 2007 Jun; 7():117. PubMed ID: 17584932
[TBL] [Abstract][Full Text] [Related]
7. Modelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary prevention.
Unal B; Critchley JA; Capewell S
BMJ; 2005 Sep; 331(7517):614. PubMed ID: 16107431
[TBL] [Abstract][Full Text] [Related]
8. Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels.
Critchley JA; Capewell S
J Epidemiol Community Health; 2003 Apr; 57(4):243-7. PubMed ID: 12646537
[TBL] [Abstract][Full Text] [Related]
9. Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data.
Hotchkiss JW; Davies CA; Dundas R; Hawkins N; Jhund PS; Scholes S; Bajekal M; O'Flaherty M; Critchley J; Leyland AH; Capewell S
BMJ; 2014 Feb; 348():g1088. PubMed ID: 24503058
[TBL] [Abstract][Full Text] [Related]
10. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: modelling study.
Bandosz P; O'Flaherty M; Drygas W; Rutkowski M; Koziarek J; Wyrzykowski B; Bennett K; Zdrojewski T; Capewell S
BMJ; 2012 Jan; 344():d8136. PubMed ID: 22279114
[TBL] [Abstract][Full Text] [Related]
11. Potential reductions in United States coronary heart disease mortality by treating more patients.
Capewell S; O'Flaherty M; Ford ES; Critchley JA
Am J Cardiol; 2009 Jun; 103(12):1703-9. PubMed ID: 19539079
[TBL] [Abstract][Full Text] [Related]
12. Achieving quality indicator benchmarks and potential impact on coronary heart disease mortality.
Wijeysundera HC; Mitsakakis N; Witteman W; Paulden M; van der Velde G; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
Can J Cardiol; 2011; 27(6):756-62. PubMed ID: 21920697
[TBL] [Abstract][Full Text] [Related]
13. Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.
Unal B; Critchley JA; Fidan D; Capewell S
Am J Public Health; 2005 Jan; 95(1):103-8. PubMed ID: 15623868
[TBL] [Abstract][Full Text] [Related]
14. Small changes in United Kingdom cardiovascular risk factors could halve coronary heart disease mortality.
Unal B; Critchley JA; Capewell S
J Clin Epidemiol; 2005 Jul; 58(7):733-40. PubMed ID: 15939226
[TBL] [Abstract][Full Text] [Related]
15. Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?
Critchley JA; Capewell S; Unal B
J Clin Epidemiol; 2003 Jun; 56(6):583-90. PubMed ID: 12873654
[TBL] [Abstract][Full Text] [Related]
16. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
17. Increasing evidence-based treatments to reduce coronary heart disease mortality in Sweden: quantifying the potential gains.
Björck L; Capewell S; Bennett K; Lappas G; Rosengren A
J Intern Med; 2011 Apr; 269(4):452-67. PubMed ID: 21205025
[TBL] [Abstract][Full Text] [Related]
18. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997.
Laatikainen T; Critchley J; Vartiainen E; Salomaa V; Ketonen M; Capewell S
Am J Epidemiol; 2005 Oct; 162(8):764-73. PubMed ID: 16150890
[TBL] [Abstract][Full Text] [Related]
19. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle].
Savonitto S; Klugmann S
Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860
[TBL] [Abstract][Full Text] [Related]
20. Decline of coronary heart disease mortality in The Netherlands from 1978 to 1985: contribution of medical care and changes over time in presence of major cardiovascular risk factors.
Bots ML; Grobbee DE
J Cardiovasc Risk; 1996 Jun; 3(3):271-6. PubMed ID: 8863098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]